Phase 1 Coagulation Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

Sepsis Associated Disseminated Intravascular Coagulation (DIC)

Bayer16 enrolled2 locationsNCT07176728

Recruiting

Phase 1

Phase I Study of MT1011 Injection in Healthy Subjects

Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation

Shaanxi Micot Pharmaceutical Technology Co., Ltd.40 enrolled1 locationNCT07024160